ENTERO — Entero Healthcare Solutions Share Price
Last trade - 00:00- IN₹57.47bn
- IN₹60.15bn
- IN₹39.22bn
- 45
- 23
- 78
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 31.57 | ||
| PEG Ratio (f) | 0.77 | ||
| EPS Growth (f) | 69.98% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.42 | ||
| Price to Tang. Book | 4.55 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.2 | ||
| EV to EBITDA | 39.75 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.77% | ||
| Return on Equity | 7.7% | ||
| Operating Margin | 2.55% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 13,496.23 | 17,797.37 | 25,220.65 | 33,002.07 | 39,223.1 | 51,794.5 | 69,317 | 30.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +128.12 | +69.98 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 10th, 2018
- Public Since
- February 16th, 2024
- No. of Shareholders
- 81,082
- No. of Employees
- 3,240
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 43,507,707
- Address
- Unit No. 605 & 606, MUMBAI, 400051
- Web
- https://www.enterohealthcare.com/
- Phone
- +91 2269019100
- Auditors
- MSKA & Associates
Similar to ENTERO
Borosil Scientific
National Stock Exchange of India
HVAX Technologies
National Stock Exchange of India
Laxmi Dental
National Stock Exchange of India
Mohini Health & Hygiene
National Stock Exchange of India
Nureca
National Stock Exchange of India
FAQ
As of Today at 20:27 UTC, shares in Entero Healthcare Solutions are trading at IN₹1,322.60. This share price information is delayed by 15 minutes.
Shares in Entero Healthcare Solutions last closed at IN₹1,322.60 and the price had moved by +13.08% over the past 365 days. In terms of relative price strength the Entero Healthcare Solutions share price has outperformed the S&P BSE 100 Index by +6.52% over the past year.
The overall consensus recommendation for Entero Healthcare Solutions is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreEntero Healthcare Solutions does not currently pay a dividend.
Entero Healthcare Solutions does not currently pay a dividend.
Entero Healthcare Solutions does not currently pay a dividend.
To buy shares in Entero Healthcare Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,322.60, shares in Entero Healthcare Solutions had a market capitalisation of IN₹57.47bn.
Here are the trading details for Entero Healthcare Solutions:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ENTERO
Based on an overall assessment of its quality, value and momentum Entero Healthcare Solutions is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Entero Healthcare Solutions is IN₹1,629.30. That is 23.19% above the last closing price of IN₹1,322.60.
Analysts covering Entero Healthcare Solutions currently have a consensus Earnings Per Share (EPS) forecast of IN₹24.65 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Entero Healthcare Solutions. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -0.28%.
As of the last closing price of IN₹1,322.60, shares in Entero Healthcare Solutions were trading +0.37% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Entero Healthcare Solutions PE ratio based on its reported earnings over the past 12 months is 31.57. The shares last closed at IN₹1,322.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Entero Healthcare Solutions' directors